{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:34:14Z","timestamp":1791185654067,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.jconrel.2004.04.011","type":"journal-article","created":{"date-parts":[[2004,6,12]],"date-time":"2004-06-12T16:41:09Z","timestamp":1087058469000},"page":"67-74","source":"Crossref","is-referenced-by-count":118,"title":["In vitro study of release mechanisms of paclitaxel and rapamycin from drug-incorporated biodegradable stent matrices"],"prefix":"10.1016","volume":"98","author":[{"given":"Frank","family":"Alexis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subbu S.","family":"Venkatraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh Kumar","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddy","family":"Boey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2004.04.011_BIB1","series-title":"Biomaterials Science: An Introduction to Materials in Medicine","year":"1996"},{"key":"10.1016\/j.jconrel.2004.04.011_BIB2","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0142-9612(96)86738-X","article-title":"Role of polymers in improving the results of stenting in coronary arteries","volume":"17","author":"Peng","year":"1996","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.jconrel.2004.04.011_BIB3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1056\/NEJM199602293340903","article-title":"Three-year follow-up after implantation of metallic coronary artery stents","volume":"334","author":"Kimura","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2004.04.011_BIB4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.CIR.102.4.399","article-title":"Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans","volume":"102","author":"Tamai","year":"2000","journal-title":"Circle"},{"key":"10.1016\/j.jconrel.2004.04.011_BIB5","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0142-9612(02)00640-3","article-title":"Collapse pressures of biodegradable stents","volume":"24","author":"Venkatraman","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2004.04.011_BIB6","doi-asserted-by":"crossref","unstructured":"S.S. Venkatraman, F.Y.C. Boey, Prosthetic device and uses therefor, Provisional patent filed, June 2003.","DOI":"10.1016\/S0924-0136(03)00829-X"},{"key":"10.1016\/j.jconrel.2004.04.011_BIB7","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ccd.10034","article-title":"Stent-based antirestenotic coating (sirolimus\/paclitaxel)","volume":"55","author":"Oberhoff","year":"2002","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.jconrel.2004.04.011_BIB8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/(SICI)1522-726X(199905)47:1<107::AID-CCD23>3.0.CO;2-8","article-title":"The right stuff (to the right place, at the right dose\u2026)","volume":"47","author":"Heldman","year":"1999","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.jconrel.2004.04.011_BIB9","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/00007890-200110150-00001","article-title":"Rapamycin: clinical results and future opportunities","volume":"72","author":"Kahan","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.jconrel.2004.04.011_BIB10","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/01.CIR.104.8.852","article-title":"Bench to bedside, the development of rapamycin and its applications to stent restenosis","volume":"104","author":"Marx","year":"2001","journal-title":"Circle"},{"key":"10.1016\/j.jconrel.2004.04.011_BIB11","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1161\/01.CIR.103.2.192","article-title":"Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angioplasty and three-dimensional intravascular ultrasound study","volume":"103","author":"Sousa","year":"2001","journal-title":"Circle"},{"key":"10.1016\/j.jconrel.2004.04.011_BIB12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/(SICI)1097-0215(19970127)70:3<297::AID-IJC9>3.0.CO;2-S","article-title":"Anti-neoplastic activity of paclitaxel on experimental superficial bladder cancer: in vivo and in vitro studies","volume":"70","author":"Nativ","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2004.04.011_BIB13","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1161\/hc3101.092214","article-title":"Physiological transport forces govern drug distribution for stent-based delivery","volume":"104","author":"Hwang","year":"2001","journal-title":"Circle"},{"key":"10.1016\/j.jconrel.2004.04.011_BIB14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1557\/PROC-394-55","article-title":"The sustained release of galardin and taxol from gelatin chondroitin sulfate coarcevate films","volume":"394","author":"Heller","year":"1995","journal-title":"Mat. Res. Soc. Symp. Proc."},{"key":"10.1016\/j.jconrel.2004.04.011_BIB15","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0735-1097(98)00312-X","article-title":"Intraluminal delivery of a specific tyrosine kinase inhibitor with biodegradable stent suppresses the restenotic changes of the coronary artery in pigs in vivo","volume":"32","author":"Yamawaki","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jconrel.2004.04.011_BIB16","series-title":"Biomaterials and Bioengineeing Handbook","first-page":"313","article-title":"Drug delivery systems for treatment of restenosis","author":"Fishbein","year":"2000"},{"key":"10.1016\/j.jconrel.2004.04.011_BIB17","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1172\/JCI117867","article-title":"Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat","volume":"95","author":"Sollot","year":"1995","journal-title":"J. Clin. Interv."},{"key":"10.1016\/j.jconrel.2004.04.011_BIB18","unstructured":"AHFS Drug Information, American Society of Health-System Pharmacists, Bethesda, 1989, pp. 1075\u20131086."},{"key":"10.1016\/j.jconrel.2004.04.011_BIB19","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJM199504133321507","article-title":"Drug therapy: paclitaxel (Taxol)","volume":"332","author":"Rowinsky","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2004.04.011_BIB20","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1016\/S0735-1097(00)01020-2","article-title":"Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months","volume":"36","author":"Drachman","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jconrel.2004.04.011_BIB21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/(SICI)1097-4636(199811)42:2<331::AID-JBM19>3.0.CO;2-L","article-title":"Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly(ethylene oxide)\u2013poly(lactide\/glycolide) nanospheres","volume":"42","author":"Suh","year":"1998","journal-title":"J. Biomed. Mater. Res."},{"issue":"5","key":"10.1016\/j.jconrel.2004.04.011_BIB22","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/01.CIR.0000050367.65079.71","article-title":"Local drug delivery via a coronary stent with programmable release pharmacokinetics","volume":"107","author":"Finkelstein","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2004.04.011_BIB23","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/jps.2600841015","article-title":"Pharmaceutical and physical properties of paclitaxel (Taxol\u00ae) complexes with cyclodextrins","volume":"84","author":"Sharma","year":"1995","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2004.04.011_BIB24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1021\/js950286j","article-title":"Binding of taxol to plastic and glass containers and protein under in vitro conditions","volume":"85","author":"Song","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2004.04.011_BIB25","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s002469900359","article-title":"Rapamycin (Sirolimus) inhibits heart cell growth in vitro","volume":"19","author":"Burton","year":"1998","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.jconrel.2004.04.011_BIB26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-5173(00)00617-7","article-title":"Solubilization of rapamycin","volume":"213","author":"Simamora","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2004.04.011_BIB27","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","article-title":"A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization","volume":"346","author":"Morice","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2004.04.011_BIB28","article-title":"Sirolimus inhibits restenosis irrespective of the vessel size: a subanalysis of the multicenter RAVEL trial","volume":"58A","author":"Regar","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jconrel.2004.04.011_BIB29","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0735-1097(02)02704-3","article-title":"Sirolimus-eluting stent for treatment of complex in-stent restenosis, the first clinical experience","volume":"41","author":"Degertekin","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jconrel.2004.04.011_BIB30","first-page":"58","article-title":"Stent-based delivery of sirolimus for the prevention of restenosis","volume":"35","author":"Klugherz","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jconrel.2004.04.011_BIB31","article-title":"Controlled release from bioerodible polymers: effect of drug type and polymer composition","author":"Alexis","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2004.04.011_BIB32","series-title":"Controlled Release of Biologically Active Agents","first-page":"39","article-title":"Diffusion-controlled systems","author":"Baker","year":"1987"},{"key":"10.1016\/j.jconrel.2004.04.011_BIB33","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0142-9612(95)93258-F","article-title":"Hydrolytic degradation devices based on poly(dl-lactic acid) size dependence","volume":"16","author":"Grizzi","year":"1995","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2004.04.011_BIB34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0168-3659(99)00012-7","article-title":"Lidocaine loaded biodegradable nanaospheres: II. Modelling of drug release","volume":"60","author":"Polakovi\u010d","year":"1999","journal-title":"J. Control. Release"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836590400197X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836590400197X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T03:56:00Z","timestamp":1549511760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836590400197X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S016836590400197X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2004.04.011","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}